EDITAS MEDICINE, INC. Increase (Decrease) in Restricted Cash
EDITAS MEDICINE, INC. (EDIT) reported Increase (Decrease) in Restricted Cash of $1.62 million for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-03.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInRestrictedCash · last filed 2017-11-08
- EDITAS MEDICINE, INC. increase (decrease) in restricted cash for the quarter ending 2016-12-31 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in restricted cash for the quarter ending 2016-09-30 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in restricted cash for the quarter ending 2016-06-30 was $0.00.
- EDITAS MEDICINE, INC. increase (decrease) in restricted cash for the quarter ending 2016-03-31 was $1.62M.
- EDITAS MEDICINE, INC. increase (decrease) in restricted cash for fiscal 2016 was $1.62M.
| Period end | Increase (Decrease) in Restricted Cash 3 month | Increase (Decrease) in Restricted Cash 6 month | Increase (Decrease) in Restricted Cash 9 month | Increase (Decrease) in Restricted Cash 12 month |
|---|---|---|---|---|
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $0.00 derived: sum of 3 quarters · filed 2017-11-08 | $1.62M 10-K · filed 2017-03-03 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $0.00 derived: sum of 2 quarters · filed 2017-11-08 | $1.62M 10-Q · filed 2017-11-08 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $1.62M 10-Q · filed 2017-08-09 | ||
| 2016-03-31 | $1.62M 10-Q · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |